FDA’s approach to evidence-based decision-making may not be addressed to the right people.
Experts contend that FDA clinical trials fail to ensure adequate consideration of women’s health needs.
Exploring FDA’s toolkit for encouraging study sponsors to meet diversity goals.
Scholars explore regulatory reforms to expand noncitizens’ access to health care.
With cyberattacks on medical devices on the rise, scholars examine regulatory challenges and solutions.
Scholar argues that COVID-19 has underscored the serious gaps in access to midwifery care.
Experts explore the impact of concussion legislation on adolescent health and education.
Scholars discuss public health harms from the underregulation of factory farms and propose potential solutions.
Scholar highlights the fragmented regulatory environment governing advanced neurological technology.
Experts discuss the role of regulations in monitoring experimental overdose prevention programs.
Two scholars find that the removal of FDA health warnings prompts an increase in drug marketing.
Regulators should expand the types of medical professionals who can prescribe COVID-19 drugs.